F18.950
BillableInhalant use, unspecified with inhalant-induced psychotic disorder with delusions
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is F18.950 an HCC code?
Yes. F18.950 maps to Drug/Alcohol Psychosis under the CMS-HCC V28 risk adjustment model (and Drug/Alcohol Psychosis under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for F18.950
For F18.950 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed F18.950 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
F18.950 is the ICD-10-CM diagnosis code for inhalant use, unspecified with inhalant-induced psychotic disorder with delusions. This code describes a person who uses inhalants (such as glue, paint thinner, or other volatile substances) and has developed a serious mental condition involving psychotic symptoms, specifically false beliefs (delusions) that feel completely real to them. The inhalant use pattern is not specified as occasional, regular, or in remission. F18.950 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).
Under the CMS-HCC V28 risk adjustment model, F18.950 maps to Drug/Alcohol Psychosis (HCC 135) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, F18.950 mapped to the same category but with a base RAF weight of 0.434 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify documentation clearly states both the inhalant use disorder and the psychotic disorder with delusions before assigning this code; do not assume psychosis is inhalant-induced without explicit clinical documentation. Because F18.950 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for F18.950 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify documentation clearly states both the inhalant use disorder and the psychotic disorder with delusions before assigning this code; do not assume psychosis is inhalant-induced without explicit clinical documentation
- •Check if the inhalant use pattern can be more specifically documented (F18.920 for in remission, F18.921 for in early remission, or F18.922 for in sustained remission) as this may provide more accurate clinical information
Clinical Significance
This code captures substance-induced psychotic disorder, which represents a serious psychiatric complication of inhalant use. Substance-induced psychosis significantly increases healthcare utilization, emergency department visits, and hospitalization risk, making accurate capture critical for risk adjustment. These patients require intensive psychiatric management and close monitoring for progression to chronic psychotic disorders.
Documentation Requirements
- ✓Provider documentation of inhalant use, specifying the type of inhalant when known (e.g., toluene, gasoline, aerosol propellants, nitrites)
- ✓Documentation of substance use pattern; query provider to determine if abuse or dependence criteria are met for more specific coding
- ✓Documentation of fixed false beliefs (delusions) that developed during or shortly after substance use and are directly attributable to the substance
- ✓Assessment and plan addressing the substance use disorder with treatment approach documented
Commonly Confused Codes
- •F18.10-F18.19 (Inhalant abuse codes) — use when documentation supports a pattern of harmful use without dependence
- •F18.20-F18.29 (Inhalant dependence codes) — use when documentation supports physiological or psychological dependence
- •F18.94 / F18.14 / F18.24 (Inhalant-induced mood disorder) — mood disorder presents with depression or mania, not psychotic features like delusions or hallucinations
- •F18.951 / F18.151 / F18.251 (Inhalant-induced psychotic disorder with hallucinations) — hallucinations are false sensory perceptions, while delusions are fixed false beliefs
- •F19.x codes (Other psychoactive substance use) — F19 is for substances other than inhalants; use F18 specifically when the substance is an inhalant